Skip to main content
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
6.15
+0.26 (4.41%)
At close: Mar 9, 2026, 4:00 PM EDT
6.20
+0.05 (0.81%)
After-hours: Mar 9, 2026, 6:31 PM EDT

Atea Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
55
Market Cap
489.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021351.37M302.73M622.49%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Vanda Pharmaceuticals 216.11M
Century Therapeutics 113.34M
Zevra Therapeutics 84.39M
Assembly Biosciences 37.19M
Lineage Cell Therapeutics 14.56M
Altimmune 41.00K
Revenue Rankings

AVIR News

More News